UnB and association establish partnership to advance research with medicinal cannabis
Three-year agreement aims to enhance extraction processes and quality control of therapeutic products in the Federal District
Published on 11/27/2025

Researchers work on quality control and improvement of cannabis-based products in the laboratory of the Institute of Chemistry. Image: Fernanda Vasconcelos/IQ
The University of Brasília (UnB) has consolidated an important scientific partnership with the Brazilian Association of Pito do Pango (Abrapango). The central objective is to deepen the study of extraction processes and quality control of therapeutic products based on medicinal cannabis.
The initiative is the result of the efforts of professors Ana Cristi Basile and Fernanda Vasconcelos, from the Institute of Chemistry (IQ). The agreement was signed by the Dean of Research and Innovation (DPI) in August and officially celebrated in September. With a duration of three years, the cooperation ensures the continuity of research and opens up new avenues of work.
"Our expectation is that this collaboration will strengthen over this period, advancing later to an agreement that will allow the development of new products, processes, and technologies," says Fernanda Vasconcelos in a statement from UnB.
Structure of medicinal cannabis research

Under the current agreement, Abrapango provides product samples, while UnB offers students, laboratory infrastructure, and technical-scientific support. The professor explains that the partnership goes beyond the laboratory bench.
"We are working together on organizing the second Cann&Quim [Cannabis and Chemistry Symposium] in the Federal District, scheduled for 2026. The cooperation involves not only research but also integrated actions of scientific dissemination," highlights Fernanda.
For the coming years, the goal is to increase the number of students dedicated to the topic of medicinal cannabis. The plan includes deepening the understanding of the adaptation of different seeds to Brazilian soils and establishing partnerships with other associations.
Advancements in quality and safety

The joint work arose from contacts with an association in the Federal District that connected Abrapango to the researchers. Fernanda Vasconcelos emphasizes the importance of regularizing the partner entity for the advancement of studies.
"We were very pleased to get to know Abrapango, one of the few associations with a court order authorizing research in partnership with universities," she says. This allowed her and Professor Ana Cristi to advance studies on medicinal cannabis, including analyses of resins in addition to diluted oils.
The partnership aims to enhance the quality of the produced oils, conducting analyses of cannabinoids and terpenes. The support includes optimizing seed selection and extraction methods, strengthening the training of new researchers in master's and doctoral programs.
UnB as a reference in medicinal cannabis
The University plays a central role in the scientific advancement of the field in Brazil. According to Fernanda, there is an explicit interest from the Rectorate in consolidating UnB as a national reference in medicinal cannabis, engaging with an existing tradition in the institution.
The professor mentions pioneers like Andréa Galassi, from UnB Ceilândia, whose studies indicate that the plant can act as an exit route to more harmful drugs. Also mentioned are professors Renato Malcher and Sidarta Ribeiro, references in neuroscience and the therapeutic effects of the plant.
"By joining the new research center, we are pleased to join this group that leads scientific production on medicinal cannabis in Brazil," expresses Fernanda. The expectation is that the center will bring together other universities, consolidating the country's potential as a producer of knowledge.
Social and therapeutic impact
From a social perspective, the partnership aims to enable associations to produce quality oils at low cost. This can lead to significant improvements in the health of elderly individuals with Alzheimer's and Parkinson's, children with epilepsy, and patients with chronic pain or anxiety.
The researchers emphasize that the safety in using medicinal cannabis depends on responsibility and monitoring. The greatest risk lies in the use without guidance on doses and drug interactions. Therefore, increasing scientific knowledge and professional training is essential for safe and effective therapeutic use.
Content published on the UNB portal with curation by Sechat.
